Pregled bibliografske jedinice broj: 1273407
Glycans as biomarkers and funcƟonal effectors in diabetes
Glycans as biomarkers and funcƟonal effectors in diabetes // 45th FEBS Congress
online ; Ljubljana, Slovenija, 2021. S-09.1-3, 1 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1273407 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Glycans as biomarkers and funcƟonal effectors in
diabetes
Autori
Gornik Kljaić, Olga
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
45th FEBS Congress
Mjesto i datum
Online ; Ljubljana, Slovenija, 03.07.2021. - 08.07.2021
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
glycosylation, diabetes
Sažetak
Accumulating evidence is demonstrating that N glycosylation participates in various processes involved in the regulation and maintenance of glucose homeostasis and is tightly connected to nutrient sensing through the hexosamine biosynthetic pathway. Distinctive N glycosylation profiles are reported for different diabetes subtypes. Proinflammatorylike changes of plasma Nglycome were noticed in crosssectional studies of type 2 diabetes mellitus (T2DM) and N glycans showed the ability in identifying individuals at high risk of disease development. Individuals with a higher risk due to recorded hyperglycemia through acute illness had increased complexity of plasma Nglycome, possibly reflecting the altered flux of glucose through the hexosamine pathway. This was subsequently confirmed in two prospective studies with incident T2DM showing that Nglycome could predict diabetes years before clinical manifestation. N glycome also showed great discriminative power in maturityonset diabetes of the young where triantennary sialylated plasma Nglycan with antennary fucose was successful in extracting individuals with damaging HNF1A mutations. As this phenomenon is also present on alpha1 acid glycoprotein, targeted analysis of specific glycopeptides could easily be incorporated in diagnostic procedures due to the increasing availability of LCMS/MS in hospital laboratories. Recently, we also analyzed glycosylation in children with type 1 diabetes mellitus (T1DM). Associations between glycan structures and genetic polymorphisms previously associated with T1DM risk were found. Differences in Nglycomes between children with T1DM and their healthy siblings possess great discriminative potential, which exceeds other predictive models used and is comparable to the most recently established genetic risk score.
Izvorni jezik
Engleski